CARTESIAN THERAPEUTICS INC
RNACNASDAQ🏆 #2897 by market capEarnings Nov 5US Equity
$8.59▼ $0.17 (−2.00%)
Market closed · at close1h—
24h▼ 2.0%
7d—
14d—
30d—
1y—
🏦Market Cap
$252M
Small Cap
📈Revenue Growth (YoY)
-94.9%
Declining
📊Gross Margin
—
💵FCF Margin
422.1%
Strong
⚖️P/S Ratio
147.6x
Expensive
Otter Score
65
Fair
📊
Analyst Ratings
Price
$8.59
Total
10
Raised
2
Lowered
2
Avg PT
$20.50
H / L
$25 / $16
| Institution | Action | Rating | Date |
|---|---|---|---|
Wedbush | Reiterated | Outperform | 2026-06-10 |
Needham | Reiterated | Buy | 2026-06-09 |
BTIG | Reiterated | Buy | 2026-06-09 |
HC Wainwright & Co. | Reiterated | Buy | 2026-05-12 |
Cantor Fitzgerald | Upgraded | Neutral → Overweight | 2026-03-09 |
Canaccord Genuity | Reiterated | Buy | 2024-07-03 |
Oppenheimer | Downgraded | Outperform → Peer Perform | 2024-07-02 |
Mizuho | Reiterated | Buy | 2023-08-18 |
SVB Leerink | Downgraded | Outperform → Market Perform | 2023-08-18 |
William Blair | Upgraded | Market Perform → Outperform | 2021-03-12 |
One row per institution, most recent rating